Canine epilepsy focus of recent research fundingNovember 4, 2024In light of National Epilepsy Awareness Month, the AKC Canine Health Foundation (CHF) has supported new studies highlighting the importance of canine epilepsy research.
SPONSORED CONTENTSupport patients' cognitive function and mobility.Cognitive and mobility decline are common issues facing aging pets, and new Hill's Prescription Diet Brain Care + j/d can help. + Learn More
Fecal transplants can reduce negative mental health symptoms in epileptic dogs, study findsSeptember 26, 2024The study, which treated dogs with drug-resistant epilepsy and behavioral issues, investigates evidence of how the gut microbiome may influence other parts of the body, particularly the brain axis.
PetPace program aims to gather canine epilepsy dataApril 13, 2018PetPace, maker of wearable technology for pets, announced a new "objective, innovative, and automated" program, PetPace Bio-Response for Epilepsy, that will allow pet owners to examine how pet biometric data changes in relation to seizure events. Epilepsy is a common condition affecting millions of dogs. As dogs spend many hours unobserved, it is difficult for pet owners to know the frequency of seizures a dog suffers. As a result, veterinarians are challenged to formulate treatment plans for epileptic patients without knowing the actual scope or frequency of seizures. As part of the PetPace Bio-Response for Epilepsy program development, PetPace is working with a large group of epileptic dogs and their owners to collect hundreds of seizure events and their correlated PetPace Smart Collar data. PetPace Bio-Response for Epilepsy collects and analyzes a range of physiological and behavioral data from owner-reported seizure events, including changes in pulse, respiration, temperature, activity, positions, HRV, and more. The PetPace analytic engine analyzes the relevant biometrics using advanced mathematical models and machine learning techniques, and provides key statistical indicators, measures, and graphical patterns that can then be used to detect future seizures, according to the company. "This technology has the potential to change the way caregivers relate …
AKC Canine Health Foundation funds clinical trial to study cannabidiol in treating drug-resistant epilepsy in dogsSeptember 14, 2017By Veterinary Practice News Editors The AKC Canine Health Foundation (CHF), which has funded more than $2 million for canine epilepsy research, launched an initiative in 2017 to further understand the most common neurological disorder that affects pure- and mixed-breed dogs. Improved treatments are urgently needed, especially for dogs with drug-resistant epilepsy or where side effects of currently available drugs are not tolerated, according to the organization. To that, the CHF has announced the beginning a major clinical trial to study the use of cannabidiol to treat drug resistant epilepsy in dogs. Stephanie McGrath, MS, DVM, DACVIM (Neurology), at Colorado State University's College of Veterinary Medicine and Biomedical Sciences, will lead "Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy." According to Dr. McGrath, up to 30 percent of dogs receiving standard anti-epileptic therapy remain uncontrolled for their seizures, and the side effects of the antiepileptic drugs are often unacceptable. CBD, a nonpsychotropic component of the Cannabis sativa plant, has been shown to have anticonvulsant properties; this randomized, double-blinded, placebo-controlled, crossover clinical trial study will be utilized to prove its effectiveness, she stated. "The timeliness and importance of research into the role of cannabis in …
NC researchers earn grant to study canine epilepsyJuly 11, 2016What causes epilepsy in dogs? A new grant awarded to two North Carolina State University College of Veterinary Medicine professors will fund research into a possible cause and treatment.
